Refresh
Company Event • 14 Mar 2024 20:00 • Upcoming
Add To Calendar
Company Event • 17 Aug 2023 20:00 • Latest
Company Event • 31 Mar 2023 20:15
Company Event • 12 Sep 2022 20:00
Company Event • 30 Aug 2022 20:15
ENTITY
I-Mab (IMAB US)
I-Mab (IMAB US)
56
Analysis
Health Care • China
I-Mab operates as a clinical stage biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of novel biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab conducts business in China.
more
x